October 14, 2024
Latest Headlines
October 14, 2024
Radiation-Associated Secondary Cancers in Breast Cancer Harboring TP53 Germline Pathogenic Variants
The ASCO Post
October 14, 2024
Overall Survival Analysis Confirms Pembrolizumab Regimen as Standard of Care for Triple-Negative Breast Cancer
The ASCO Post
October 14, 2024
Updated Findings in Prostate Cancer Screening With Systemic Biopsy vs MRI-Targeted Biopsy
The ASCO Post
Daily News
Stay up to date with the latest clinical headlines.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
October 11, 2024
Global Disparities May Exist in Availability, Timeliness of New Cancer Drugs
The ASCO Post
October 11, 2024
10 Under 10: Georgia dentist carries torch of dental family legacy into the future
ADA News
October 11, 2024
FDA Approves Inavolisib Combination in PIK3CA-Mutated, HR-Positive, HER2-Negative Advanced Breast Cancer
The ASCO Post
Advertisement
Recommendations
Advertisement